Literature DB >> 12835699

CpG motifs: the active ingredient in bacterial extracts?

Arthur M Krieg1.   

Abstract

The use of bacteria and bacterial extracts for immunotherapy has a checkered past. Recent developments in immunology reveal that these nonspecific immune activators actually work by triggering specific receptors that are expressed by subsets of immune cells. Identification of these receptors and the molecular signaling pathways that they activate has enabled a new era of specific targeted immunotherapy using chemically synthesized mimics of pathogen molecules.

Mesh:

Substances:

Year:  2003        PMID: 12835699     DOI: 10.1038/nm0703-831

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  68 in total

1.  Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides.

Authors:  Arthur M Krieg
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

2.  Of men, mice and pigs: looking at their plasmacytoid dendritic cells [corrected].

Authors:  Hubertus Hochrein; Hermann Wagner
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

Review 3.  From genes to drugs: targeted strategies for melanoma.

Authors:  Keith T Flaherty; F Stephen Hodi; David E Fisher
Journal:  Nat Rev Cancer       Date:  2012-04-05       Impact factor: 60.716

4.  Attacks on asthma.

Authors:  Sarah Webb
Journal:  Nat Biotechnol       Date:  2011-10-13       Impact factor: 54.908

5.  Anti-tumor efficacy of plasmid encoding emm55 in a murine melanoma model.

Authors:  Brittany L Bunch; Krithika N Kodumudi; Ellen Scott; Jennifer Morse; Amy Mackay Weber; Anders E Berglund; Shari Pilon-Thomas; Joseph Markowitz
Journal:  Cancer Immunol Immunother       Date:  2020-06-18       Impact factor: 6.968

6.  Dysbiosis in inflammatory bowel disease.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

7.  Antitumor activity of G3139 lipid nanoparticles (LNPs).

Authors:  Xiaogang Pan; Li Chen; Shujun Liu; Xiaojuan Yang; Jian-Xin Gao; Robert J Lee
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

Review 8.  Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.

Authors:  Audry Fernández; Liliana Oliver; Rydell Alvarez; Luis E Fernández; Kelvin P Lee; Circe Mesa
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

9.  Transferrin receptor targeted lipopolyplexes for delivery of antisense oligonucleotide g3139 in a murine k562 xenograft model.

Authors:  Xulang Zhang; Chee Guan Koh; Bo Yu; Shujun Liu; Longzhu Piao; Guido Marcucci; Robert J Lee; L James Lee
Journal:  Pharm Res       Date:  2009-03-17       Impact factor: 4.200

10.  Human immunodeficiency virus type 1 infection induces cyclin T1 expression in macrophages.

Authors:  Li-Ying Liou; Christine H Herrmann; Andrew P Rice
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.